Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 25.93 CNY -5.57% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Beijing Kawin Technology Share-holding Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Kawin Technology Share-holding Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Cash from Operating Activities
ÂĄ126.6m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-ÂĄ7.8B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
ÂĄ1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Operating Activities
ÂĄ796.9m
CAGR 3-Years
-13%
CAGR 5-Years
9%
CAGR 10-Years
13%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
ÂĄ6.5B
CAGR 3-Years
-12%
CAGR 5-Years
54%
CAGR 10-Years
43%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
ÂĄ2B
CAGR 3-Years
66%
CAGR 5-Years
71%
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
44.38 CNY
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
126.6m CNY

Based on the financial report for Dec 31, 2023, Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities amounts to 126.6m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
16%

Over the last year, the Cash from Operating Activities growth was -6%. The average annual Cash from Operating Activities growth rates for Beijing Kawin Technology Share-holding Co Ltd have been -1% over the past three years , 16% over the past five years .

Back to Top